BACKGROUND: The development of a simple, reliable, valid and responsive method for measuring the extent of skin involvement in psoriasis is important for use in epidemiological studies. OBJECTIVES: We sought to investigate the psychometric characteristics of the Patient Report of Extent of Psoriasis Involvement (PREPI), a single-question method for measuring body surface area affected by psoriasis. METHODS: This was a cross-sectional study of 140 patients with psoriasis, with an exploratory prospective longitudinal cohort component. Reliability was measured via a test-retest approach and criterion validity was investigated by comparing the PREPI with an assessment of body surface area of involvement by a dermatologist. We additionally compared Skindex-29 scores with the PREPI. To demonstrate responsiveness and establish a minimally important difference in the PREPI, we created receiver operating characteristic curves for the PREPI instrument. RESULTS: The test-retest reliability of the PREPI was nearly perfect [intraclass correlation coefficient (ICC) = 0.99, 95% confidence interval (CI) 0.97-0.99], and there was substantial agreement between patient and physician assessments (ICC = 0.82, 95% CI 0.75-0.87). The PREPI showed significant correlations with all Skindex-29 domains. We found the PREPI to be responsive to change and identified changes in the PREPI score that have good discrimination between patients with and without a minimally important clinical difference. CONCLUSIONS: Our study suggests that the PREPI is a reliable, valid and responsive measure of body surface area affected by psoriasis that may be useful for future epidemiological research.
BACKGROUND: The development of a simple, reliable, valid and responsive method for measuring the extent of skin involvement in psoriasis is important for use in epidemiological studies. OBJECTIVES: We sought to investigate the psychometric characteristics of the Patient Report of Extent of Psoriasis Involvement (PREPI), a single-question method for measuring body surface area affected by psoriasis. METHODS: This was a cross-sectional study of 140 patients with psoriasis, with an exploratory prospective longitudinal cohort component. Reliability was measured via a test-retest approach and criterion validity was investigated by comparing the PREPI with an assessment of body surface area of involvement by a dermatologist. We additionally compared Skindex-29 scores with the PREPI. To demonstrate responsiveness and establish a minimally important difference in the PREPI, we created receiver operating characteristic curves for the PREPI instrument. RESULTS: The test-retest reliability of the PREPI was nearly perfect [intraclass correlation coefficient (ICC) = 0.99, 95% confidence interval (CI) 0.97-0.99], and there was substantial agreement between patient and physician assessments (ICC = 0.82, 95% CI 0.75-0.87). The PREPI showed significant correlations with all Skindex-29 domains. We found the PREPI to be responsive to change and identified changes in the PREPI score that have good discrimination between patients with and without a minimally important clinical difference. CONCLUSIONS: Our study suggests that the PREPI is a reliable, valid and responsive measure of body surface area affected by psoriasis that may be useful for future epidemiological research.
Authors: Joel M Gelfand; Steven R Feldman; Robert S Stern; John Thomas; Tara Rolstad; David J Margolis Journal: J Am Acad Dermatol Date: 2004-11 Impact factor: 11.527
Authors: Joel M Gelfand; Daniel B Shin; Andrea L Neimann; Xingmei Wang; David J Margolis; Andrea B Troxel Journal: J Invest Dermatol Date: 2006-06-01 Impact factor: 8.551
Authors: Junko Takeshita; Shuwei Wang; Daniel B Shin; Nehal N Mehta; Stephen E Kimmel; David J Margolis; Andrea B Troxel; Joel M Gelfand Journal: JAMA Dermatol Date: 2015-02 Impact factor: 10.282
Authors: Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand Journal: JAMA Dermatol Date: 2013-10 Impact factor: 10.282
Authors: Sinéad M Langan; Nicole M Seminara; Daniel B Shin; Andrea B Troxel; Stephen E Kimmel; Nehal N Mehta; David J Margolis; Joel M Gelfand Journal: J Invest Dermatol Date: 2011-11-24 Impact factor: 8.551
Authors: Alexis Ogdie; W Benjamin Nowell; Eddie Applegate; Kelly Gavigan; Shilpa Venkatachalam; Marie de la Cruz; Emuella Flood; Ethan J Schwartz; Beverly Romero; Peter Hur Journal: BMC Rheumatol Date: 2020-01-10
Authors: George Gondo; Edward Hadeler; Nicholas Brownstone; Emanual Maverakis; Joseph F Merola; April W Armstrong; Tina Bhutani; Stacie J Bell; Wilson Liao Journal: Dermatol Ther (Heidelb) Date: 2022-03-07
Authors: George Gondo; Megan Mosca; Julie Hong; Emanual Maverakis; Joseph F Merola; April W Armstrong; Tina Bhutani; Stacie J Bell; Wilson Liao Journal: Dermatol Ther (Heidelb) Date: 2022-07-21
Authors: M M Lokhorst; S E R Horbach; M Waner; T M O; C J M van der Vleuten; L B Mokkink; C M A M van der Horst; P I Spuls Journal: Br J Dermatol Date: 2019-12-02 Impact factor: 9.302